COMBINATION THERAPY WITH RAR ALPHA AGONISTS FOR ENHANCING TH1 RESPONSE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 3, 2016
app pub date -
Mar 8, 2016
filing date -
Mar 9, 2015
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Encompassed are methods of potentiating anti-tumor immunity comprising administering an RARα agonist to a patient having a tumor in combination with at least one other treatment and methods of suppressing a Th17 response in a patient comprising administering an RARα agonist in combination with at least one other treatment.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully